Connect with us

Health

Pfizer already working on COVID-19 vaccine targeting Omicron: CEO

Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the new Omicron variant in case the current inoculation is not effective against the latest strain, the US drugmaker's CEO Albert Bourla said Monday.

Bourla told CNBC that his company on Friday began testing the current vaccine against the Omicron variant, which was first reported in South Africa and has reignited fears of a global wave of Covid-19 infections.

“I don't think the result will be the vaccines don't protect,” Bourla said.

For more coronavirus news, visit our dedicated page.

But the testing could show that existing shots “protect less,” which would mean “that we need to create a new vaccine,” Bourla said.

“Friday we made our first DNA template, which is the first possible inflection of the development process of a new vaccine,” he said.

Johnson & Johnson also said Monday that it is “pursuing an Omicron-specific variant vaccine and will progress it as needed.”

On Friday, Moderna, another leading Covid-19 vaccine maker, said it was developing a booster shot against the new variant.

Bourla likened the situation to the scenario earlier this year when Pfizer and its German partner BioNTech developed a vaccine in 95 days when there were concerns the previous formula would not work against Delta, though that version ultimately was not used.

The current vaccine is “very effective” against Delta, the executive said, adding that the companies expect to be able to produce four billion vaccine doses in 2022.

On Monday, the World Health Organization warned the new Covid-19 Omicron variant poses a “very high” risk globally.

Bourla said he was also “very confident” that Pfizer's recently unveiled antiviral pill would work as a treatment for infections caused by the mutations, including Omicron.

Among newly-infected, high risk patients treated within three days of the onset of symptoms, Pfizer's pill has been shown to cut hospitalization or death by nearly 90 percent.

For the latest headlines, follow our Google News channel online or via the app.

Read more:

Omicron poses ‘very high’ global health risk, countries must prepare: WHO

First image of Omicron shows many more mutations than Delta variant

WHO says PCR tests detect Omicron, new COVID-19 variant has higher reinfection risk

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Explainer: What is famine and how is it declared?

Amid growing global concerns over alarming hunger spikes in conflict-affected communities and talk of intensifying levels of food insecurity possibly leading to famine, we looked into how – and when – a famine is classified.

Continue Reading

Health

WHO study shows $39 return for each dollar invested in fight against TB

The UN World Health Organization (WHO) on Monday called for a funding boost in tuberculosis (TB) screening and prevention programmes to protect vulnerable populations and achieve key health goals.

Continue Reading

Health

‘Historic milestone’ as child mortality hits record low of 4.9 million in 2022

The fight against child mortality has reached an historic milestone the UN announced on Wednesday with latest estimates revealing the number of children dying prematurely before their fifth birthday fell to 4.9 million in 2022.

Continue Reading

Trending